To explore the molecular mechanisms and potential clinical significance of CD28+PD-1+ Tc cells in HCC, we conducted multidimensional analyses, including TMB, drug sensitivity prediction, and TIDE scoring, based on the enrichment level of CD28+PD-1+ Tc cells. Here, CD28 is linked to hepatocellular carcinoma.